A multicenter, open label, phase 3 study of tabelecleucel for solid organ transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disorder (EBV+PTLD) after failure of rituximab or rituximab and chemotherapy (ALLELE) Meeting Abstract
| Authors: | Prockop, S. E.; Hiremath, M.; Ye, W.; Gamelin, L.; Navarro, W. H.; Mahadeo, K. M. |
| Abstract Title: | A multicenter, open label, phase 3 study of tabelecleucel for solid organ transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disorder (EBV+PTLD) after failure of rituximab or rituximab and chemotherapy (ALLELE) |
| Meeting Title: | Transplantation and Cellular Therapy Meetings of ASBMT and CIBMTR |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 26 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2020 Feb 19-23 |
| Meeting Location: | Orlando, FL |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-03-01 |
| Start Page: | S274 |
| Language: | English |
| ACCESSION: | WOS:000516887900412 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2019.12.444 |
| Notes: | Meeting Abstract: 413 -- Source: Wos |
